2025 ICD-10-CM code G30.8
(Active) Effective Date: N/A Diseases of the nervous system - Other degenerative diseases of the nervous system 6 Feed
This code signifies a diagnosis of Alzheimer's disease that doesn't fall under the early-onset or late-onset classifications.
Medical necessity for services related to Alzheimer's disease is established by demonstrating the presence of cognitive impairment significantly impacting the patient's daily functioning and quality of life. This includes documentation of the severity of symptoms, the need for ongoing monitoring and management, and the potential benefits of interventions such as medication, therapy, and supportive care.
The diagnosis and management of Alzheimer's disease typically falls under the purview of specialists like neurologists, geriatricians, and psychiatrists. Primary care physicians also play a crucial role in initial assessments and ongoing care coordination.The clinical responsibility encompasses a comprehensive approach, including thorough evaluation, diagnostic testing, medication management (e.g., donepezil, rivastigmine, galantamine, memantine), behavioral interventions, and supportive care to address the multifaceted challenges posed by the disease. Collaboration with other healthcare professionals, such as occupational therapists, physical therapists, social workers, and caregivers, is essential to provide holistic patient care.
In simple words: This signifies a type of Alzheimer's disease that is different from the typical early or late-onset forms. It's a brain disorder that gradually gets worse, causing memory loss, confusion, and problems with thinking and daily tasks.It affects how a person lives their life.
Other Alzheimer disease (AD) encompasses cases that are not specifically classified as early-onset (presenile) or late-onset (senile).It represents a progressive neurodegenerative disorder marked by dementia, impacting memory, cognitive function, and consequently, personal, social, and occupational life. While the exact cause remains unclear, genetic factors are suspected, particularly in early-onset cases.The disease manifests in stages, with initial symptoms including memory decline exceeding normal age-related changes, cognitive difficulties (wandering, disorientation, financial mismanagement, repetitive questioning, slowed task completion), and personality changes. As it advances, language, reasoning, and thinking abilities deteriorate, leading to heightened confusion, difficulty recognizing familiar faces, hallucinations, delusions, paranoia, and impulsivity.Severe stages involve brain tissue shrinkage, weight loss, incontinence, loss of communication, complete dependence, and confinement to bed. Death often results from secondary illnesses like pneumonia. Diagnosis involves medical history review, symptom assessment, physical and psychological evaluations, standardized memory tests, and often, laboratory and imaging studies (thyroid and liver function tests, vitamin B12 levels, tests for syphilis, CSF protein analysis, CT, MRI, SPECT, PET) to eliminate other potential causes of dementia.
Example 1: A 70-year-old patient presents with progressive memory loss and cognitive decline, but their symptoms don't perfectly align with typical early-onset or late-onset Alzheimer's disease. After extensive evaluation, including neuropsychological testing and imaging studies, the diagnosis of atypical Alzheimer's disease is made, and G30.8 is used for coding., A 55-year-old individual exhibits symptoms of dementia, but their clinical presentation and biomarker profile are unusual. After ruling out other potential causes, the physician documents "other Alzheimer's disease" to reflect the atypical nature of the condition, coded as G30.8., A 62-year-old patient with a family history of early-onset Alzheimer's starts experiencing memory problems and difficulties with executive function. While their age might suggest early-onset, the specific genetic markers are absent, and the clinical picture is more consistent with a mixed presentation. The physician uses G30.8 to capture the complexity of the diagnosis.
Documentation should include detailed descriptions of the patient's cognitive and behavioral symptoms, results of neuropsychological testing, imaging findings (CT, MRI, PET), and any relevant laboratory tests.It's also essential to document the physician's rationale for classifying the Alzheimer's disease as "other," clearly stating why it doesn't fit the criteria for early-onset or late-onset subtypes.
** It is important to note that G30.8 is used for Alzheimer's disease that doesn't fall into the early-onset or late-onset categories. This code allows for more specific classification of atypical or mixed presentations of Alzheimer's disease. Clinicians should ensure thorough documentation to justify the use of this code and accurately reflect the patient's condition.
- Payment Status: Active
- Specialties:Neurology, Geriatrics, Psychiatry, Family Medicine, Internal Medicine
- Place of Service:Inpatient Hospital, Office, Nursing Facility, Home Health